SMECTA SACHET 3 gsachet

Country: Singapore

Language: English

Source: HSA (Health Sciences Authority)

Active ingredient:

DIOCTAHEDRAL SMECTITE

Available from:

DKSH SINGAPORE PTE. LTD.

ATC code:

A07BC05

Dosage:

3g/sachet

Pharmaceutical form:

POWDER

Composition:

DIOCTAHEDRAL SMECTITE 3g/sachet

Administration route:

ORAL

Prescription type:

General Sale List

Manufactured by:

BEAUFOUR IPSEN INDUSTRIE

Authorization status:

ACTIVE

Authorization date:

1991-07-03

Patient Information leaflet

SMECTA
® ORANGE-VANILLA FLAVOR
Dioctahedral Smectite - 3 g
Before you start to take your medicine, please read this leaflet
carefully all the way through as it
contains important information.
If there is anything that you do not understand or if you need further
information or advice, you should
consult your pharmacist or doctor who will have further details.
INFORMATION ABOUT THIS MEDICINE
NAME:
SMECTA®, powder for oral suspension.
COMPOSITION:
The active substance is
Dioctahedral Smectite……3.00 g in each sachet
The other ingredients are:
Glucose monohydrate, saccharine sodium, orange-vanilla flavour
(containing sucrose)
PHARMACEUTICAL FORM AND PACK SIZE:
Powder for oral suspension.
Box of 10 or 30 sachets.
DESCRIPTION:
SMECTA® is packed in soft, flat sachet. The product is presented as
off-white to light beige powder,
with slightly reminiscent odour of orange when preparing the oral
suspension for use.
PHARMACO-THERAPEUTIC CLASSIFICATION:
Antidiarrheal
Gastro-intestinal protectant
(A: Alimentary tract and metabolism)
PHARMACODYNAMIC PROPERTIES:
Due to its leaflet structure and its high plastic viscosity, SMECTA®
possesses a powerful coating property
on the gastrointestinal mucosa. By interacting with glycoprotein of
mucus, SMECTA® increases the
resistance of the mucosal gel in response to aggressive agents.
By its action on the gastrointestinal mucous barrier and its high
binding capacity, SMECTA® protects the
gastrointestinal mucosa.
SMECTA® is radiolucent, does not colour the stools and, at usual
doses, does not modify the
physiological intestinal transit time.
PHARMACOKINETIC PROPERTIES:
According to structure of dioctahedral smectite (active ingredient),
SMECTA® is neither absorbed nor
metabolized.
WHAT IS THIS MEDICINE USED FOR?
-
Treatment of acute diarrhoea in children of 2 years and above, in
addition to oral rehydration.
-
Treatment of acute diarrhoea in adults.
-
Symptomatic treatment of chronic functional diarrhoea in adults.
Fluid and electrolyte depletion may occur in patients who have